uniQure Director Plans $1.3M Stock Sale Under 10b5-1 Plan
uniQure N.V.
Subscribe to track QURE
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
uniQure Director Plans $1.3M Stock Sale Under 10b5-1 Plan
Company: uniQure N.V. (QURE) Form: 144 | Filed: 2025-11-04 Significance: Low
Insider: Kaye Jack Title: Director | Relationship: Director
Transaction: • Type: Sale (Proposed) • Shares: 38,810 • Price: ~$34.29 • Value: $1,330,794 • Owned After: Not Disclosed
Key Insight: A director has filed a notice to sell shares valued at approximately $1.3M. The transaction is part of a pre-scheduled 10b5-1 trading plan, which significantly reduces its market-moving implications.
Market Context: The sale represents a negligible fraction (0.063%) of the company's $2.11B market cap and is unlikely to impact the stock.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: uniQure N.V. (QURE)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director at uniQure has filed a notice of proposed sale for $1.33 million worth of stock, executed under a pre-arranged 10b5-1 trading plan.
- Market Impact: Minimal impact is expected due to the transaction's small size relative to the company's market capitalization and its pre-scheduled nature.
Company Information
| Field | Value |
|---|---|
| Company | uniQure N.V. |
| Ticker Symbol | QURE |
| CIK | 0001590560 |
| Industry | PHARMACEUTICAL PREPARATIONS |
Insider Information
| Field | Value |
|---|---|
| Name | Kaye Jack |
| CIK | 0001376099 |
| Title/Position | Director |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 |
| Transaction Date | 2025-11-04 |
| Transaction Code | S (Sale) |
| Security Type | ORDINARY SHARES |
| Shares Involved | 38,810 |
| Price Per Share | $34.29 |
| Total Value | $1,330,794 |
| Shares Owned After | Not Disclosed |
| Ownership Type | Not Disclosed |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $1,330,794 |
| % of Market Cap | 0.063% |
| Shares Transacted | 38,810 |
| % of Shares Outstanding | 0.071% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The $1.33M sale is minor compared to uniQure's $2.11 billion market capitalization.
- Transaction Significance: The sale represents less than 0.1% of both the market cap and shares outstanding, falling well below thresholds for moderate or high significance.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is immaterial in size. Furthermore, its execution under a 10b5-1 plan adopted in June 2025 indicates it is a planned liquidity event rather than a reaction to current company developments.
Volume & Sentiment
- Expected Volume Impact: Negligible. The number of shares is unlikely to affect daily trading volume in a meaningful way.
- Sentiment Indicator: Neutral. Pre-planned sales by directors are routine and typically do not influence market sentiment.
Additional Context
Special Circumstances
- The filing explicitly states the sale is pursuant to a 10b5-1 trading plan. This plan allows insiders to establish a pre-arranged schedule for selling company stock, providing an affirmative defense against insider trading accusations.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.